LONG-TERM RESULTS OF TREATMENT OF ENDOMETRIAL CANCER OF IBG1-2 STAGE
Litsenziya: cc-by
Annotatsiya
In a retrospective study, the results of treatment of 548 patients with endometrial cancer (EС) of intermediate risk of IBG1-2 stage for 2006–2010 were evaluated. The overall, cancer-specific and disease-free 5-year survival rate was 83.7 ± 1.6, 91.2 ± 1.2, 88.4 ± 1.4 %. The best treatment results were obtained during combined treatment with the use of simple hysterectomy with bilateral salpingo-oophorectomy and adjuvant extra-beam radiation therapy. Chemotherapy did not improve the treatment results. A joint application in the treatment regimen of pelvic lymphadenectomy and adjuvant extrabeam radiation therapy on the pelvic regimen is impractical, since it does not affect the survival rate. Differences in survival rates in the regions were established at the stage of IBG1-2. Despite the fact that the methods of treatment of this stage of EC are standardized, the differences obtained can be evidence of an insufficiently effective quality of treatment in a number of regions of the Republic. In regions with the lowest survival rates, attention should be paid to the technique of operations, how adequately the extrafascial hysterectomy is performed, the length of the resected vaginal cuff, the start time, the dose and duration of radiation therapy, the size of the irradiation fields and the volume of irradiated tissues, the equipment for radiation therapy and others.
Hali tarjima qilinmagan